Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer

Journal:
Science Advances
Published:
DOI:
10.1126/sciadv.abf2567
Affiliations:
5
Authors:
13
Institutions Authors Share
Hudson Institute of Medical Research, Australia
8.000000
0.62
University of Michigan (U-M), United States of America (USA)
2.000000
0.15
Ruijin Hospital, SJTU, China
1.500000
0.12
Monash University, Australia
1.000000
0.08
University of Oxford, United Kingdom (UK)
0.500000
0.04